LinkedIn Google+ Twitter Facebook

Carisome® Posters, Papers, Abstracts & Presentations

Learn more about the promise of Carisome Technology from the data presented at recent meetings.

2013 International Society for Extracellular Vesicles (ISEV)

Circulating Microvesicles Contain Critical Elements of the RISC Complex

Effect of Colonoscopy on Circulating Microvesicles

Identification and Implications of Transcription Factors in Circulating Microvesicles From Cancer Patients

Multicolor Flow Cytometric Analysis of Cancer-Derived Microvesicles Reveals a Unique Subpopulation Ratio in Plasma From Prostate Cancer Patients

American Association for Cancer Research (AACR) 2012

GW182 Associates With Circulating Microvesicles in Human Plasma

Differential Protein Expression and miR Content of Sorted Subsets of Circulating Microvesicles From Cancer Patients and Health Controls

A Novel Blood-Based Method of Evaluating KRAS in Circulating Microvesicles From Colorectal Patients

American Urological Association (AUA) 2011

Analysis of a Circulating Microvesicle-Based Assay in At-Risk Patients for the Detection of Prostate Cancer

American Association for Cancer Research (AACR) 2011

Plasma-Derived Circulating Microvesicles Can Both Detect and Help Monitor Breast Cancer–Related Pathologies

Enriching for Rare Subpopulations of Circulating Microvesicles by the Depletion of Endothelial- and Leukocyte-Derived Microvesicles

Comparison of miR Expression Patterns in Plasma, Serum, and Cell Line Microvesicles

Subpopulations of Circulating Microvesicles Have Different MicroRNA Profiles

Detection of Lung Cancer From Plasma Using the Biosignature of Circulating Microvesicles

American Association for Cancer Research (AACR) 2010

Plasma exosome-based biosignatures: A novel method for early diagnosis of colorectal cancer

Plasma exosomes are a robust biosignature for prostate cancer

Important differences between exosome biosignatures from prostate cancer patient plasma samples and prostate cancer cell lines

Identification and characterization of exosome subpopulations to provide the foundation for a novel exosome-based cancer diagnostic platform

American Society of Clinical Oncology (ASCO) 2010

A sensitive exosome-based biosignature for the diagnosis of prostate cancer

Circulating exosomes may provide an alternate platform to monitor disease progression compared to circulating tumor cells

Caris Presents

Caris Life Sciences Molecular Oncology Services

Caris' scientific experts contribute to the advancement of science at various symposia and conferences worldwide.

learn more


David D. Halbert Chairman & CEO